Authors

Andy Studna

Andy Studna is a senior editor for Pharmaceutical Executive and Applied Clinical Trials. He can be reached at [email protected].

CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor

8 months ago

Industry experts talk with PharmTech, Pharmaceutical Commerce, Applied Clinical Trials, and Pharmaceutical Executive about FDA's CNPV pilot program.

Katherine Ulman

Katherine Ulman is the owner and Primary for KLU Consulting, LLC.She retired from Dow Corning Corporation after more than 40 years of employment.While at Dow Corning, she held positions as a global regulatory compliance manager for their Healthcare business as well as regulatory manager of the Dow Corning Healthcare Industries Materials Site.

Co-Processed Excipients: Practical Engineered Solutions for Modern Pharmaceutical Challenges

4 months ago

This article details what co-processed excipients are and how they are made.

Authors

CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor

Co-Processed Excipients: Practical Engineered Solutions for Modern Pharmaceutical Challenges

Trending on Pharmaceutical Technology

PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers

A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations

Andelyn Biosciences Partners with Queen's University on GM2 Gangliosidosis Gene Therapy

Dersimelagon Acquisition Highlights Shift Toward Late-Stage Rare Disease Licensing

Q&A: Why Sponsors Are Turning to Mixed FSP/FSO Models